Brokerages Set Gain Therapeutics, Inc. (NASDAQ:GANX) Price Target at $8.20
Gain Therapeutics, Inc. (NASDAQ:GANX – Get Free Report) has been assigned an average recommendation of “Buy” from the six ratings firms that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target […]
Gain Therapeutics, Inc. (NASDAQ:GANX – Get Free Report) has been assigned an average recommendation of “Buy” from the six ratings firms that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target […]
